Mechanism of NO2-induced migraine in rats: The exploration of the role of miR-653-3p/IGF1 axis

Ye, Shuzi; Wei, Lai; Jiang, Yan; Yuan, Yu; Zeng, Yuan; Zhu, Lemei; Xiao, Fang

doi:10.1016/j.jhazmat.2023.133362

Cited by 1 publication

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A previous MR study showed that increased levels of IGF1 are causally associated with decreased migraine risk [ 45 ]. Recent experimental results suggest that the miR-653-3p/IGF1 axis regulating the AKT/TRPV1 signaling pathway may be a potential pathogenic mechanism for migraine [ 46 ]. The beneficial effects of TGF-β3 and IGF1 on migraine may be associated with the regulation of gene expression in different microenvironments to promote the transition of microglial cells from M1 (pathogenic) to M2 (protective) phenotypes [ 47 ].…”

Section: Discussionmentioning

confidence: 99%

Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization

Zhang,

He,

Liu

2024

J Headache Pain

View full text Add to dashboard Cite

Background Currently, the treatment and prevention of migraine remain highly challenging. Mendelian randomization (MR) has been widely used to explore novel therapeutic targets. Therefore, we performed a systematic druggable genome-wide MR to explore the potential therapeutic targets for migraine. Methods We obtained data on druggable genes and screened for genes within brain expression quantitative trait locis (eQTLs) and blood eQTLs, which were then subjected to two-sample MR analysis and colocalization analysis with migraine genome-wide association studies data to identify genes highly associated with migraine. In addition, phenome-wide research, enrichment analysis, protein network construction, drug prediction, and molecular docking were performed to provide valuable guidance for the development of more effective and targeted therapeutic drugs. Results We identified 21 druggable genes significantly associated with migraine (BRPF3, CBFB, CDK4, CHD4, DDIT4, EP300, EPHA5, FGFRL1, FXN, HMGCR, HVCN1, KCNK5, MRGPRE, NLGN2, NR1D1, PLXNB1, TGFB1, TGFB3, THRA, TLN1 and TP53), two of which were significant in both blood and brain (HMGCR and TGFB3). The results of phenome-wide research showed that HMGCR was highly correlated with low-density lipoprotein, and TGFB3 was primarily associated with insulin-like growth factor 1 levels. Conclusions This study utilized MR and colocalization analysis to identify 21 potential drug targets for migraine, two of which were significant in both blood and brain. These findings provide promising leads for more effective migraine treatments, potentially reducing drug development costs.

show abstract

Section: Discussionmentioning

confidence: 99%